We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IFL:ASXInsignia Financial Ltd Analysis

Data as of 2026-03-15 - not real-time

A$4.66

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Insignia Financial (IFL) is trading at AUD 4.66, just above its 20‑day SMA of 4.65 and 50‑day SMA of 4.64, indicating a mild bullish bias. The RSI of 52.5 sits in neutral territory, while the MACD histogram is slightly negative, giving a bearish signal on momentum. Support sits at 4.58 and resistance at 4.72, leaving a modest upside of roughly 2‑3% to the DCF‑derived fair value of 4.76. Volatility over the past 30 days is 10.3% and beta is only 0.48, suggesting the stock moves less than the market. The Fear‑Greed Index at 72.9 signals a “greed” market tone, which can inflate price expectations. Despite a current PE of 27.4 versus an industry average of 16.4, the forward PE collapses to 11.5, reflecting sharply higher expected earnings.
The latest half‑year earnings showed revenue up 1.8% to AUD 718 million and net profit up 6% to AUD 132 million, confirming the 7.8% YoY revenue growth trend. Operating margins remain healthy at 21.4% and cash flow from operations is AUD 286 million, though free cash flow is slightly negative. Debt stands at AUD 1.02 billion with a debt‑to‑equity of 47.9%, a manageable level for a financial services firm. The forward EPS of 0.405 is more than double the trailing 0.17, underpinning the low forward PE and analyst median target of AUD 4.80. With no dividend payout, the stock’s appeal rests on earnings growth and capital appreciation. Overall, the combination of modest technical upside, improving earnings outlook, and low market sensitivity supports a cautiously optimistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram signaling short‑term momentum weakness
  • Price near support level of 4.58
  • Decreasing volume trend reducing immediate liquidity

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 11.5 indicating significant earnings upside
  • DCF fair value suggests ~2.5% upside
  • Strong half‑year earnings growth and improving margins

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustainable earnings growth but modest ROE (~5%)
  • Manageable debt levels with low beta (0.48) reducing market risk
  • No dividend policy, reliance on capital appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth7.80%
Profit Margin6.80%
P/E Ratio27.4
ROE5.36%
ROA6.03%
Debt/Equity47.87
P/B Ratio1.5
Op. Cash FlowA$286.2M
Free Cash FlowA$-52987500
Industry P/E16.4

Technical Analysis

TrendBullish
RSI52.5
SupportA$4.58
ResistanceA$4.72
MA 20A$4.65
MA 50A$4.64
MA 200A$4.41
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$4.76
Target PriceA$4.78
Upside/Downside2.58%
GradeFair
TypeGrowth

Risk Assessment

Beta0.48
Volatility10.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.